Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Surveys and Questionnaires × Gynecologic × Clear all

Phase

Phase NA 14 Phase 3 2 Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7 human papillomavirus vaccine, L1 type 16, 18 5 niraparib 4 Human Papillomavirus Recombinant Vaccine nonavalent 4 Vaccines 3 Saline Solution 3 Papillomavirus Vaccines 3 Carboplatin 3 pegylated granulocyte colony-stimulating factor 2 olaparib 2 liposomal doxorubicin 2 fluciclovine F-18 2 apatinib 2 Sevoflurane 2 Propofol 2 Paclitaxel 2 Medroxyprogesterone Acetate 2 Bevacizumab 2 pegfilgrastim 1 pazopanib 1 palbociclib 1 lenvatinib 1 ganirelix 1 gadofosveset trisodium 1 fosaprepitant 1 ferrous fumarate 1 epoetin beta 1 dostarlimab 1 cetrorelix 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02837926 2019-04-10

CoheaHr-WP4

CHU de Reims

Phase 4 Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡